La conclusión principal es que el tipo de personalidad basal es el determinante más importante del impacto emocional tras un resultado alterado en el cribado de cérvix. Otros factores que también ...
Read moreUn proyecto multicéntrico europeo que ha obtenido 1,3 millones de euros de financiación para avanzar frente al adenocarcinoma ductal pancreático (PDAC), uno de los cánceres de páncreas más agres...
Read moreCancer cells do not act alone. Through complex communication networks and signalling pathways, tumour cells and their microenvironment coordinate adaptive responses that drive drug resistance. Underst...
Read moreAccording to the results, cancer patients with lower muscle mass are 2.5 times more likely to develop peripheral nerve damage because of chemotherapy.
Read moreA team led by scientists from the University of Zaragoza at INMA (CSIC-Unizar) uses "ultrasmall" Pt particles, measuring 2-3 nm, to multiply the effectiveness of radiotherapy.
Read moreUn estudio experimental del CBM-CSIC-UAM identifica pequeñas moléculas de ARN que bloquean el crecimiento de células tumorales y abre nuevas vías terapéuticas
Read moreIn first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a composite complete remission rate (CRc) of 93% (with 79% CR), and an estimated 12-mon...
Read moreA team from the Universitat Rovira i Virgili is investigating a new approach to treating cancer and pulmonary hypertension by targeting drugs exclusively at diseased tissue
Read moreAn international study led by IDIBELL-ICO, iS3-IPATIMUP and the CIBER network, framed within the European consortium Solve-RD and the European reference network ERN-GENTURIS, has managed to increase g...
Read moreRubén Pérez-Mañanes: “A public hospital can sustain a regulated, multidisciplinary and scientifically productive manufacturing unit without compromising its healthcare mission”
Read moreEste estudio en fase 2 impulsado por el Cancer Center Clínica Universidad de Navarra pretende abrir nuevas vías terapéuticas frente a estas enfermedades sin cura y que necesitan más apoyo para la ...
Read morePartnership during the last 8 years leverages VIVEbiotech’s decade of experience manufacturing GMP ex- and in- vivo lentiviral vectors for the advanced therapies sector
Read more